Dignitana AB

DIGN

SE0002108001

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 16:07:15 28/06/2024 BST			5-day change	1st Jan Change
1.51 ^SEK	-2.58%		-0.66%	-30.73%

06-24	Dignitana Deputy Chairman Resigns	MT
06-24	Dignitana AB Announces the Resignation of William Cronin as Deputy Chairman of the Board, Effective 24 June 2024	CI

Dignitana AB Announces the Resignation of William Cronin as Deputy Chairman of the Board, Effective 24 June 2024

June 24, 2024 at 04:10 am

Dignitana AB (publ) announced that William Cronin, Deputy Chairman of the Board, has resigned from the Board of Directors. Citing personal reasons, his resignation takes effect 24 June 2024.

Latest news about Dignitana AB

Dignitana Deputy Chairman Resigns	06-24	MT
Dignitana AB Announces the Resignation of William Cronin as Deputy Chairman of the Board, Effective 24 June 2024	06-24	CI
Dignitana AB Approves the Election of Fredrik Lindgren and Hope S. Rugo as Board Members	05-23	CI
Dignitana AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-23	CI
Dignitana, Konica Minolta Enter Multi-year Exclusive Distribution Deal in Japan	05-21	MT
Dignitana Signs an Exclusivity Agreement for Japan with Konica Minolta	05-21	CI
Dignitana AB Announces Chief Executive Officer Changes , Effective May 2, 2024	04-24	CI
Dignitana Raises SEK19 Million via Rights Issue of Shares	04-04	MT
Dignicap Delta Study Underway in Brindisi, Italy	03-07	CI
Sweden's Dignitana to Raise SEK19 Million via Rights Issues, Secures SEK5 Million Bridge Loan	02-22	MT
Dignitana AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-15	CI
Dignitana AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-15	CI
Dignitana Receives Japanese Market Approval for Medical Device for Cancer Patients	02-12	MT
Dignitana Announces DigniCap Delta Receives Market Approval in Japan	02-12	CI
Dignitana Announces Preliminary Results of DigniCap Delta Study Demonstrates 79% Efficacy	01-16	CI
Dignitana Signs Exclusive Distribution Deal with OncoMedical	01-15	MT
Dignitana AB Signs OncoMedical AG for Distribution in Switzerland and Liechtenstein	01-15	CI
Dignitana AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
Dignitana AB Appoints Nomination Committee	11-07	CI
Dignitana Signs Sales & Marketing Deal With US-based InfuSystem; Shares Drop	04/10/23	MT
Dignitana AB Announces Sales and Marketing Partnership with InfuSystem Holdings, Inc. to Provide Scalp Cooling Systems in the United States	04/10/23	CI
Palmetto GBA Medicare Contractor Backs Dignitana's Scalp Cooling Solution for Cancer Patients	03/10/23	MT
Dignitana AB Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	03/10/23	CI
Dignitana AB Long-Term Study Demonstrates Safety and Efficacy of Scalp Cooling to Reduce Chemo Hair Loss	17/08/23	CI
Dignitana AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/08/23	CI

Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold cap, which when put on the patientâs head, lowers the temperature of the scalp. The low temperature reduces perfusion, delivery of blood and metabolism. The reduced blood flow results in a smaller amount of chemotherapy available for uptake in the cells, while the decreased temperature results in less absorption and reduced effects of chemotherapy. These factors together reduce the risk of hair loss. The DigniCap scalp cooling system is patented in Europe, Japan and the United States. It has a subsidiary BrainCool AB, which focuses on producing different models of brain cooling for stroke and cardiac arrest patients.

Sector

Medical Equipment, Supplies & Distribution

Calendar

21/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Dignitana AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
DIGNITANA AB	-30.73%	11.75M
SHOCKWAVE MEDICAL	+75.67%	12.57B
MASIMO CORPORATION	+8.09%	6.98B
PENUMBRA, INC.	-29.41%	6.78B
GETINGE AB	-19.73%	4.59B
APT MEDICAL INC.	+17.40%	4.15B
ASAHI INTECC CO., LTD.	-21.37%	3.83B
INARI MEDICAL, INC.	-24.94%	2.73B
SKAN GROUP AG	-1.24%	2B
NOVOCURE LIMITED	+15.07%	1.9B

Medical Equipment

Dignitana AB

Equities

DIGN

SE0002108001

Medical Equipment, Supplies & Distribution

Dignitana AB Announces the Resignation of William Cronin as Deputy Chairman of the Board, Effective 24 June 2024

Latest news about Dignitana AB

Chart Dignitana AB

Company Profile

Income Statement Evolution

Ratings for Dignitana AB

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Equipment